Elements® is the U.S. division of parent company Neopharm, dedicated to introduce our best products redesigned and repackaged for the U.S. marketplace
1996
Neopharm company was founded.
Elements® is the U.S. division of parent company Neopharm, dedicated to introduce our best products redesigned and repackaged for the U.S. marketplace
As we constantly strive to meet the increasing demands of work and family in today’s fast-paced world, it’s easy to sacrifice own good health in the process. But when a single element essential to wellness is missing, overall quality of life can suffer. Because when we’re not feeling our best, it’s much more difficult to do our best...
Elements® is the U.S. division of parent company Neopharm, dedicated to introducing our best products tailor-made for the U.S. consumer.
Neopharm company was founded.
Neopharm trades in medicinal products, substances and chemicals, both domestically and internationally.
Neopharm starts manufacturing and launches its first product: Neopholic, folic acid for pregnant women.
Neopharm participates as a General Sponsor of the National Convention on Obstetrics and Gynecology.
Bulgarian University Hospitals start first clinical studies with Neopharm’s product.
Bulgarian Urological Society and Bulgarian Nephrological Society publish official guides that recommend the use of Neorenal SR, the flagman of Neopharm’s portfolio.
Neopharm participates in the charity Initiative "300 Babies More," held at Bulgaria's largest University Obstetric Gynecology Hospital, by donating "Neopholic" folic acid.
Neopharm launchs Novarix, a new solution for support supplementation targeting structure/function of the vein. Along with well-studied ingredients, the formula includes collagen and elastin peptides, with benefits for the connective tissue structure.
Neopharm opens a new production facility certified to ISO 22000:2005 and HACCP by TUV Rheinland.
Neopharm begins development of probiotic strains. Today, more than 130 strains are isolated and 5 of them are in phase I clinical trial, with promising in vitro and in vivo results.
Neopharm launches Neopholic meta, the second L-methylfolate formula in Europe made to support women before and during their pregnancy.
Neopharm develops the first in the world D-mannose matrix for steady release technology, integrated in Cystostop SR, specially designed for women to support their UT health.
Resista Forte, known in the US as “Supreme Immunity,” wins the Food Supplement of the Year Award from the Bulgarian Pharmaceutical Union.
Neopharm receives a certificate for USA FDA Registration.
Neopharm creates its international brand: Elements. Elements attends the ECRM® EPPS event in Phoenix, Arizona.
Neopharm conducts the largest double blind, placebo-controlled, randomized clinical trial among patients from three age groups with clinical diagnosis of acute respiratory viral infection. A year later, the results of the study are published in Folia medica, confirming the antiviral activity of Aviron Rapid, known also as Winter Rescue under the Elements brand.
Currently, Neopharm has 38 original products under its registered trade mark.
Science. Efficacy. Excellence.
We are devoted to positively impacting health through innovation, science, and continued care.
Elements® is the U.S. division of parent company Neopharm, dedicated to introducing our best products tailor-made for the U.S. consumer.
Enter your email below for updates.